Aardvark reveals positive data for ARD-101 in treating obesity or other metabolic conditionsAardvark Therapeutics has reported positive clinical data from three Phase II trials for its lead product ARD-101, an oral small molecule...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment3 days ago